GDF-15 and Early Outcomes After LVAD Implantation
Association of Preoperative GDF-15 Levels With Early Postoperative Outcomes and Mortality After LVAD Implantation
Akdeniz University
48 participants
Feb 4, 2026
OBSERVATIONAL
Conditions
Summary
This observational study aims to investigate the association between preoperative GDF-15 levels and early postoperative outcomes in patients undergoing left ventricular assist device (LVAD) implantation. The study will evaluate whether elevated preoperative GDF-15 levels are associated with adverse early outcomes, including postoperative complications and mortality. The findings may help improve preoperative risk assessment and identify high-risk patients before LVAD implantation.
Eligibility
Inclusion Criteria3
- Patients with advanced heart failure undergoing LVAD implantation
- Availability of preoperative GDF-15 measurement
- Ability to provide written informed consent or consent provided by a legally authorized representative, according to local regulations -
Exclusion Criteria6
- Active infection
- Active malignancy
- Severe hepatic failure
- Missing study data
- Refusal to participate
- \-
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07497308